Susquehanna International Group’s Alimera Sciences ALIM Stock Holding History

Susquehanna International Group’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-18,600	Closed	-$103K	–	13327
2024 Q2	$103K	Buy	+18,600	New	+$66.1K	﹤0.01%	11010
2017 Q4	–	Sell	-667	Closed	-$14K	–	10048
2017 Q3	$14K	Buy	+667	New	+$14.3K	﹤0.01%	8674
2015 Q2	–	Sell	-1,200	Closed	-$90K	–	10541
2015 Q1	$90K	Sell	1,200 -2,573	-68%	-$202K	﹤0.01%	9000
2014 Q4	$314K	Sell	3,773 -23,307	-86%	-$1.89M	﹤0.01%	8053
2014 Q3	$2.2M	Buy	27,080 +22,827	+537%	+$1.95M	﹤0.01%	4436
2014 Q2	$382K	Buy	4,253 +3,386	+391%	+$301K	﹤0.01%	7969
2014 Q1	$103K	Sell	867 -1,420	-62%	-$138K	﹤0.01%	8553
2013 Q4	$162K	Buy	+2,287	New	+$93.2K	﹤0.01%	8411

Susquehanna International Group's ALIM Position: Q2 2024 in Review

Susquehanna International Group sold out of Alimera Sciences (ALIM) in Q2 2024, closing a stake of 107,101 shares — an estimated $380K sold.

Susquehanna International Group first reported a position in ALIM in Q4 2013 and held it in 17 quarters. The position peaked at $979K in Q3 2014. 52 funds tracked by Wall St. Rank hold ALIM as of Q2 2024.

Susquehanna International Group reported no remaining Alimera Sciences position as of Q2 2024 after selling out during the quarter.
Susquehanna International Group sold 107,101 Alimera Sciences shares in Q2 2024, an estimated $380K.
Susquehanna International Group first reported a position in Alimera Sciences in Q4 2013 and held it in 17 quarters.
Susquehanna International Group's Alimera Sciences position peaked at $979K in Q3 2014.
52 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.